(Q39259300)

English

A novel adipocytokine visfatin protects against H(2)O(2) -induced myocardial apoptosis: a missing link between obesity and cardiovascular disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A novel adipocytokine visfatin protects against H(2)O(2) -induced myocardial apoptosis: a missing link between obesity and cardiovascular disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

author name string

Jing Xiao

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Bing Sun

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ming Li

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ying Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Xiao-Bo Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

228

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

495-501

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Reactive oxygen species, cellular redox systems, and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Metabolism and circadian rhythms--implications for obesity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Apoptosis in heart failure. -The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes-.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

The Obesity Paradox: Fact or Fiction?

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Death receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

The novel adipocytokine visfatin exerts direct cardioprotective effects

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Isorhamnetin inhibits H₂O₂-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Transient expression of interferon-inducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Impact of obesity on cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Oxidative stress-elicited myocardial apoptosis during reperfusion

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24257

21 January 2018

Identifiers

10.1002/JCP.24257

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39259300&oldid=1816116362"